These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27915484)

  • 1. New techniques for studying airway drug pharmacokinetics for asthma therapeutics.
    Edsbäcker S
    Expert Rev Clin Pharmacol; 2017 Feb; 10(2):127-130. PubMed ID: 27915484
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
    Walenga RL; Longest PW
    J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations.
    Hein S; Bur M; Schaefer UF; Lehr CM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):132-8. PubMed ID: 20951200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma medication delivery: mists and myths.
    Rottier BL; Rubin BK
    Paediatr Respir Rev; 2013 Jun; 14(2):112-8; quiz 118, 137-8. PubMed ID: 23522986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can 'extrafine' dry powder aerosols improve lung deposition?
    de Boer AH; Gjaltema D; Hagedoorn P; Frijlink HW
    Eur J Pharm Biopharm; 2015 Oct; 96():143-51. PubMed ID: 26220014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick(™) dry-powder inhaler in the treatment of asthma.
    Welch MJ
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1109-19. PubMed ID: 27424535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metered dose inhaler with spacer versus dry powder inhaler for delivery of salbutamol in acute exacerbations of asthma: a randomized controlled trial.
    Lodha R; Gupta G; Baruah BP; Nagpal R; Kabra SK
    Indian Pediatr; 2004 Jan; 41(1):15-20. PubMed ID: 14767083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
    Gillespie M; Song S; Steinfeld J
    Allergy Asthma Proc; 2015; 36(5):365-71. PubMed ID: 26314817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhaled treatment for asthma in practice].
    Pham Thi Thuong N; Le Bourgeois M; de Blic J; Scheinmann P
    Arch Pediatr; 2004 Nov; 11(11):1377-83. PubMed ID: 15519840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could interchangeable use of dry powder inhalers affect patients?
    Price D; Summers M; Zanen P
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems with inhaler use: a call for improved clinician and patient education.
    Fink JB; Rubin BK
    Respir Care; 2005 Oct; 50(10):1360-74; discussion 1374-5. PubMed ID: 16185371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry-powder inhalers in acute asthma.
    Selroos O
    Ther Deliv; 2014 Jan; 5(1):69-81. PubMed ID: 24341818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.